Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of Butantan-DV in participants aged 2–59 years through an extended follow-up: results from a double-blind, randomised, placebo-controlled, phase 3, multicentre trial in Brazil

39

Citations

33

References

2024

Year

Maurício Lacerda Nogueira, Monica A T Cintra, J. A. A. Moreira, Elizabeth González Patiño, Patricia Emília Braga, Juliana C V Tenório, Lucas Bassolli de Oliveira Alves, Vanessa Infante, Daniela Haydee Ramos Silveira, Marcus Lacerda,

The Lancet Infectious Diseases

Patient SafetyClinical TrialsMulticentre TrialPharmacotherapyExtended Follow-upMedicinePhase 3

References

	Year	Citations

Page 1